Board of Directors

John Brown, PhD

Board Chairman

Senior Independent Director of BioCity and Acacia Pharma, and former Chairman of Cell and Gene Therapy Catapult and Synpromics. 

Previous board roles include Chairman of Axis-Shield, Chairman of BTG, Non-executive Director of Vectura and Chief Executive Officer of Acambis.

David Venables, PhD

Chief Executive Officer

Former President of AskBio Europe, CEO at Synpromics, Anatara Lifesciences and Ark Therapeutics. Founding leadership team NightStar Therapeutics. Honorary Professor, Edinburgh University.​

Elizabeth Klein, MBA

Board member

Investor Director, Calculus Capital. Board member,  MIP Discovery. 20 years experience in life science investing. Founding team Klein-Edmonds Associates.

Sue Foden, DPhil

Board member

Chair Evgen. Deputy chair Qbiotic. Member of Investment Committee CD3. Trustee Roslin Foundation. Former board positions at BTG, Vectura, BioVex, Piramed. Former investor director at VC, Merlin Biosciences and founding team Cancer Research Technologies.

Gilad Gershon, MBA

Board member

CEO Tropic Biosciences. Experienced AgriTech entrepreneur and investor, who is deeply passionate about utilizing cutting-edge technologies in solving real world challenges.